Jacob Vineberg is a pharmaceutical and healthcare industry expert with a deep background in R&D and management consulting. They served as an Associate at McKinsey & Company, where they focused on analytics and operational improvements for clients in pharmaceuticals and healthcare and led a significant transformation project that captured $5.6 billion in value. Previously, as a Senior Scientist at Pfizer, Jacob developed over 200 unique antibody-drug conjugates and played a key role in advancing several into clinical trials. Currently, they are the Executive Director and Head of US Oncology Innovation and Business Planning at AstraZeneca, guiding strategic initiatives in oncology. Jacob holds an educational background from MIT Sloan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices